Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference47 articles.
1. Rodriguez-Antona, C. & Ingelman-Sundberg, M. Cytochrome P450 pharmacogenetics and cancer. Oncogene 25, 1679–1691 (2006).
2. Estabrook, R.W. The remarkable P450s: a historical overview of these versatile hemeprotein catalysts. FASEB J. 10, 202–204 (1996).
3. Rainov, N.G. et al. New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Hum. Gene Ther. 9, 1261–1273 (1998).
4. Doloff, J.C. & Waxman, D.J. Adenoviral vectors for prodrug activation-based gene therapy for cancer. Anticancer. Agents Med. Chem. 14, 115–126 (2014).
5. Rowinsky, E.K. et al. Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans. Cancer Res. 53, 1794–1801 (1993).
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献